{"groups":[{"description":"Triple Negative Breast Cancer (TNBC) Nivolumab monotherapy (3 mg/kg) Q2W","id":"FG000","title":"TNBC Arm N"},{"description":"Triple Negative Breast Cancer (TNBC) Nivolumab (1 mg/kg) + ipilimumab (1 mg/kg) Q3W for 4 doses, then nivolumab (3 mg/kg) Q2W","id":"FG001","title":"TNBC Arm N-I Dose Level 1"},{"description":"Triple Negative Breast Cancer (TNBC) Nivolumab (1 mg/kg) + ipilimumab (3 mg/kg) Q3W for 4 doses, then nivolumab (3 mg/kg) Q2W","id":"FG002","title":"TNBC Arm N-I Dose Level 2"},{"description":"Gastric Cancer (GC) Nivolumab 3 mg/kg Q2W","id":"FG003","title":"GC Arm N"},{"description":"Gastric Cancer(GC) Nivolumab (1 mg/kg) + ipilimumab (1 mg/kg) Q3W for 4 doses, then nivolumab (3 mg/kg) Q2W","id":"FG004","title":"GC Arm N-I Dose Level 1"},{"description":"Gastric Cancer (GC) nivolumab (1 mg/kg) + ipilimumab (3 mg/kg) Q3W for 4 doses; then nivolumab 3 mg/kg Q2W","id":"FG005","title":"GC Arm N-I Dose Level 2"},{"description":"Gastric Cancer (GC) Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg Q3W for 4 doses, then Nivolumab (3 mg/kg) Q2W","id":"FG006","title":"GC Arm N-I Dose Level 2b"},{"description":"Pancreatic cancer (PC) participants: Nivolumab 3 mg/kg Q2W","id":"FG007","title":"PC Arm N"},{"description":"Pancreatic cancer (PC) participants: Nivolumab 1 mg/kg + Ipilimumab 1 mg/kg Q3W for 4 doses, then Nivolumab (3 mg/kg) Q2W","id":"FG008","title":"PC Arm N-I Dose Level 1"},{"description":"Pancreatic cancer (PC) participants: Nivolumab 1 mg/kg + Ipilimumab 3 mg/kg Q3W for 4 doses, then Nivolumab (3 mg/kg) Q2W","id":"FG009","title":"PC Arm N-I Dose Level 2"},{"description":"Pancreatic cancer (PC) participants: Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg Q6W for 4 doses + cobimetinib 60 mg po qd 21 days on/7 days off","id":"FG010","title":"PC Arm N-I Dose Level 2d"},{"description":"Small cell lung cancer (SCLC) participants treated in Pre-expansion Cohort with Nivolumab 3 mg/kg Q2W","id":"FG011","title":"SCLC Arm N - Pre-expansion"},{"description":"Small cell lung cancer (SCLC) treated participants in Pre-expansion cohort treated with Nivolumab (1 mg/kg) + ipilimumab (3 mg/kg) Q3W for 4 doses, then nivolumab (3 mg/kg) Q2W","id":"FG012","title":"SCLC Arm N-I Dose Level 2 - Pre-expansion"},{"description":"Small cell lung cancer (SCLC) expansion cohort participants: Nivolumab monotherapy (3 mg/kg) Q2W","id":"FG013","title":"SCLC Arm N Expansion"},{"description":"Small cell lung cancer (SCLC) expansion cohort participants Nivolumab (1 mg/kg) + ipilimumab (3 mg/kg) Q3W for 4 doses, then nivolumab (3 mg/kg) Q2W","id":"FG014","title":"SCLC Arm N-I Dose Level 2- Expansion"},{"description":"Small cell lung cancer (SCLC) participants treated with Nivolumab (1 mg/kg) + ipilimumab (1 mg/kg) Q3W for 4 doses, then nivolumab (3mg/kg) Q2W","id":"FG015","title":"SCLC Arm N-I Dose Level 1 -"},{"description":"Small cell lung cancer (SCLC) treated participants treated with Nivolumab (3 mg/kg) + ipilimumab (1 mg/kg) Q3W for 4 doses, then nivolumab (3 mg/kg) Q2W","id":"FG016","title":"SCLC Arm N-I Dose Level 2b"},{"description":"Bladder cancer (BC) participants: Nivolumab 3 mg/kg Q2W","id":"FG017","title":"BC Arm N"},{"description":"Bladder cancer (BC) participants: Nivolumab 1 mg/kg + Ipilimumab 3 mg/kg Q3W for 4 doses, then Nivolumab (3 mg/kg) Q2W","id":"FG018","title":"BC Arm N-I Dose Level 2"},{"description":"Bladder cancer (BC) participants: Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg Q3W for 4 doses, then Nivolumab (3 mg/kg) Q2W","id":"FG019","title":"BC Arm N-I Dose Level 2b"},{"description":"Ovarian cancer (OC) participants:\n\nNivolumab (1 mg/kg) + ipilimumab (3 mg/kg) Q3W for 4 doses, then nivolumab (3 mg/kg) Q2W","id":"FG020","title":"OC Arm N-I Dose Level 2"},{"description":"Ovarian cancer (OC) participants: Nivolumab (3 mg/kg) + ipilimumab (1 mg/kg) Q3W for 4 doses,then nivolumab (3 mg/kg) Q2W","id":"FG021","title":"OC Arm N-I Dose Level 2b"},{"description":"Ovarian cancer (OC) participants: Nivolumab (3 mg/kg) Q2W + ipilimumab (1 mg/kg) Q6W","id":"FG022","title":"OC Arm N-I Dose Level 2c:"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"17"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"12"},{"groupId":"FG003","numSubjects":"48"},{"groupId":"FG004","numSubjects":"3"},{"groupId":"FG005","numSubjects":"25"},{"groupId":"FG006","numSubjects":"38"},{"groupId":"FG007","numSubjects":"16"},{"groupId":"FG008","numSubjects":"3"},{"groupId":"FG009","numSubjects":"11"},{"groupId":"FG010","numSubjects":"22"},{"groupId":"FG011","numSubjects":"73"},{"groupId":"FG012","numSubjects":"38"},{"groupId":"FG013","numSubjects":"118"},{"groupId":"FG014","numSubjects":"59"},{"groupId":"FG015","numSubjects":"1"},{"groupId":"FG016","numSubjects":"43"},{"groupId":"FG017","numSubjects":"56"},{"groupId":"FG018","numSubjects":"50"},{"groupId":"FG019","numSubjects":"71"},{"groupId":"FG020","numSubjects":"30"},{"groupId":"FG021","numSubjects":"31"},{"groupId":"FG022","numSubjects":"31"}],"type":"Disease progression"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"3"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"9"},{"groupId":"FG006","numSubjects":"7"},{"groupId":"FG007","numSubjects":"1"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"5"},{"groupId":"FG010","numSubjects":"2"},{"groupId":"FG011","numSubjects":"3"},{"groupId":"FG012","numSubjects":"7"},{"groupId":"FG013","numSubjects":"5"},{"groupId":"FG014","numSubjects":"12"},{"groupId":"FG015","numSubjects":"0"},{"groupId":"FG016","numSubjects":"3"},{"groupId":"FG017","numSubjects":"3"},{"groupId":"FG018","numSubjects":"12"},{"groupId":"FG019","numSubjects":"15"},{"groupId":"FG020","numSubjects":"4"},{"groupId":"FG021","numSubjects":"7"},{"groupId":"FG022","numSubjects":"4"}],"type":"Study drug toxicity"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"2"},{"groupId":"FG003","numSubjects":"3"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"5"},{"groupId":"FG006","numSubjects":"1"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"2"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"12"},{"groupId":"FG012","numSubjects":"6"},{"groupId":"FG013","numSubjects":"13"},{"groupId":"FG014","numSubjects":"6"},{"groupId":"FG015","numSubjects":"1"},{"groupId":"FG016","numSubjects":"1"},{"groupId":"FG017","numSubjects":"6"},{"groupId":"FG018","numSubjects":"3"},{"groupId":"FG019","numSubjects":"5"},{"groupId":"FG020","numSubjects":"1"},{"groupId":"FG021","numSubjects":"1"},{"groupId":"FG022","numSubjects":"0"}],"type":"AE unrelated to study drug"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"3"},{"groupId":"FG006","numSubjects":"3"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"3"},{"groupId":"FG011","numSubjects":"2"},{"groupId":"FG012","numSubjects":"1"},{"groupId":"FG013","numSubjects":"2"},{"groupId":"FG014","numSubjects":"4"},{"groupId":"FG015","numSubjects":"0"},{"groupId":"FG016","numSubjects":"1"},{"groupId":"FG017","numSubjects":"3"},{"groupId":"FG018","numSubjects":"1"},{"groupId":"FG019","numSubjects":"1"},{"groupId":"FG020","numSubjects":"3"},{"groupId":"FG021","numSubjects":"1"},{"groupId":"FG022","numSubjects":"3"}],"type":"Participant request to stop therapy"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"1"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"1"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"1"},{"groupId":"FG011","numSubjects":"1"},{"groupId":"FG012","numSubjects":"1"},{"groupId":"FG013","numSubjects":"0"},{"groupId":"FG014","numSubjects":"2"},{"groupId":"FG015","numSubjects":"0"},{"groupId":"FG016","numSubjects":"2"},{"groupId":"FG017","numSubjects":"1"},{"groupId":"FG018","numSubjects":"1"},{"groupId":"FG019","numSubjects":"1"},{"groupId":"FG020","numSubjects":"0"},{"groupId":"FG021","numSubjects":"2"},{"groupId":"FG022","numSubjects":"0"}],"type":"Participant withdrew consent"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"0"},{"groupId":"FG012","numSubjects":"1"},{"groupId":"FG013","numSubjects":"0"},{"groupId":"FG014","numSubjects":"1"},{"groupId":"FG015","numSubjects":"0"},{"groupId":"FG016","numSubjects":"0"},{"groupId":"FG017","numSubjects":"1"},{"groupId":"FG018","numSubjects":"0"},{"groupId":"FG019","numSubjects":"1"},{"groupId":"FG020","numSubjects":"0"},{"groupId":"FG021","numSubjects":"0"},{"groupId":"FG022","numSubjects":"0"}],"type":"Poor/non-compliance"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"1"},{"groupId":"FG011","numSubjects":"1"},{"groupId":"FG012","numSubjects":"1"},{"groupId":"FG013","numSubjects":"0"},{"groupId":"FG014","numSubjects":"1"},{"groupId":"FG015","numSubjects":"0"},{"groupId":"FG016","numSubjects":"0"},{"groupId":"FG017","numSubjects":"0"},{"groupId":"FG018","numSubjects":"2"},{"groupId":"FG019","numSubjects":"2"},{"groupId":"FG020","numSubjects":"0"},{"groupId":"FG021","numSubjects":"0"},{"groupId":"FG022","numSubjects":"0"}],"type":"other reason"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"1"},{"groupId":"FG011","numSubjects":"1"},{"groupId":"FG012","numSubjects":"0"},{"groupId":"FG013","numSubjects":"0"},{"groupId":"FG014","numSubjects":"1"},{"groupId":"FG015","numSubjects":"0"},{"groupId":"FG016","numSubjects":"0"},{"groupId":"FG017","numSubjects":"1"},{"groupId":"FG018","numSubjects":"1"},{"groupId":"FG019","numSubjects":"0"},{"groupId":"FG020","numSubjects":"2"},{"groupId":"FG021","numSubjects":"0"},{"groupId":"FG022","numSubjects":"0"}],"type":"Maximum clinical benefit"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"0"},{"groupId":"FG012","numSubjects":"0"},{"groupId":"FG013","numSubjects":"0"},{"groupId":"FG014","numSubjects":"0"},{"groupId":"FG015","numSubjects":"0"},{"groupId":"FG016","numSubjects":"0"},{"groupId":"FG017","numSubjects":"0"},{"groupId":"FG018","numSubjects":"0"},{"groupId":"FG019","numSubjects":"0"},{"groupId":"FG020","numSubjects":"0"},{"groupId":"FG021","numSubjects":"0"},{"groupId":"FG022","numSubjects":"1"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"0"},{"groupId":"FG012","numSubjects":"0"},{"groupId":"FG013","numSubjects":"1"},{"groupId":"FG014","numSubjects":"2"},{"groupId":"FG015","numSubjects":"0"},{"groupId":"FG016","numSubjects":"0"},{"groupId":"FG017","numSubjects":"0"},{"groupId":"FG018","numSubjects":"0"},{"groupId":"FG019","numSubjects":"0"},{"groupId":"FG020","numSubjects":"0"},{"groupId":"FG021","numSubjects":"0"},{"groupId":"FG022","numSubjects":"0"}],"type":"Death"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"18"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"18"},{"groupId":"FG003","numSubjects":"59"},{"groupId":"FG004","numSubjects":"3"},{"groupId":"FG005","numSubjects":"49"},{"groupId":"FG006","numSubjects":"52"},{"groupId":"FG007","numSubjects":"18"},{"groupId":"FG008","numSubjects":"3"},{"groupId":"FG009","numSubjects":"18"},{"groupId":"FG010","numSubjects":"30"},{"groupId":"FG011","numSubjects":"98"},{"groupId":"FG012","numSubjects":"61"},{"groupId":"FG013","numSubjects":"147"},{"groupId":"FG014","numSubjects":"96"},{"groupId":"FG015","numSubjects":"3"},{"groupId":"FG016","numSubjects":"55"},{"groupId":"FG017","numSubjects":"78"},{"groupId":"FG018","numSubjects":"92"},{"groupId":"FG019","numSubjects":"104"},{"groupId":"FG020","numSubjects":"41"},{"groupId":"FG021","numSubjects":"43"},{"groupId":"FG022","numSubjects":"42"}],"comment":"Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)","type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"9"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"2"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"17"},{"groupId":"FG012","numSubjects":"0"},{"groupId":"FG013","numSubjects":"2"},{"groupId":"FG014","numSubjects":"0"},{"groupId":"FG015","numSubjects":"0"},{"groupId":"FG016","numSubjects":"0"},{"groupId":"FG017","numSubjects":"20"},{"groupId":"FG018","numSubjects":"0"},{"groupId":"FG019","numSubjects":"0"},{"groupId":"FG020","numSubjects":"0"},{"groupId":"FG021","numSubjects":"0"},{"groupId":"FG022","numSubjects":"0"}],"comment":"Participants who will transition after completing MT due to disease progression (DP)","type":"Transition"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"3"},{"groupId":"FG006","numSubjects":"6"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"1"},{"groupId":"FG009","numSubjects":"1"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"0"},{"groupId":"FG012","numSubjects":"17"},{"groupId":"FG013","numSubjects":"0"},{"groupId":"FG014","numSubjects":"2"},{"groupId":"FG015","numSubjects":"0"},{"groupId":"FG016","numSubjects":"0"},{"groupId":"FG017","numSubjects":"0"},{"groupId":"FG018","numSubjects":"1"},{"groupId":"FG019","numSubjects":"19"},{"groupId":"FG020","numSubjects":"0"},{"groupId":"FG021","numSubjects":"0"},{"groupId":"FG022","numSubjects":"0"}],"comment":"Participants who were transitioned to another treatment after disease progression (DP).","type":"Transition- Continued"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"3"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"6"},{"groupId":"FG006","numSubjects":"3"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"5"},{"groupId":"FG012","numSubjects":"6"},{"groupId":"FG013","numSubjects":"8"},{"groupId":"FG014","numSubjects":"8"},{"groupId":"FG015","numSubjects":"1"},{"groupId":"FG016","numSubjects":"5"},{"groupId":"FG017","numSubjects":"7"},{"groupId":"FG018","numSubjects":"22"},{"groupId":"FG019","numSubjects":"8"},{"groupId":"FG020","numSubjects":"1"},{"groupId":"FG021","numSubjects":"1"},{"groupId":"FG022","numSubjects":"3"}],"comment":"Completed = continuing treatment period","type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"18"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"18"},{"groupId":"FG003","numSubjects":"56"},{"groupId":"FG004","numSubjects":"3"},{"groupId":"FG005","numSubjects":"43"},{"groupId":"FG006","numSubjects":"49"},{"groupId":"FG007","numSubjects":"18"},{"groupId":"FG008","numSubjects":"3"},{"groupId":"FG009","numSubjects":"18"},{"groupId":"FG010","numSubjects":"30"},{"groupId":"FG011","numSubjects":"93"},{"groupId":"FG012","numSubjects":"55"},{"groupId":"FG013","numSubjects":"139"},{"groupId":"FG014","numSubjects":"88"},{"groupId":"FG015","numSubjects":"2"},{"groupId":"FG016","numSubjects":"50"},{"groupId":"FG017","numSubjects":"71"},{"groupId":"FG018","numSubjects":"70"},{"groupId":"FG019","numSubjects":"96"},{"groupId":"FG020","numSubjects":"40"},{"groupId":"FG021","numSubjects":"42"},{"groupId":"FG022","numSubjects":"39"}],"type":"NOT COMPLETED"}],"title":"Treatment Period"},{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"4"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"2"},{"groupId":"FG006","numSubjects":"5"},{"groupId":"FG007","numSubjects":"1"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"5"},{"groupId":"FG011","numSubjects":"8"},{"groupId":"FG012","numSubjects":"2"},{"groupId":"FG013","numSubjects":"12"},{"groupId":"FG014","numSubjects":"7"},{"groupId":"FG015","numSubjects":"0"},{"groupId":"FG016","numSubjects":"5"},{"groupId":"FG017","numSubjects":"3"},{"groupId":"FG018","numSubjects":"2"},{"groupId":"FG019","numSubjects":"7"},{"groupId":"FG020","numSubjects":"4"},{"groupId":"FG021","numSubjects":"6"},{"groupId":"FG022","numSubjects":"2"}],"type":"Participant withdrew consent"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"2"},{"groupId":"FG003","numSubjects":"6"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"6"},{"groupId":"FG006","numSubjects":"6"},{"groupId":"FG007","numSubjects":"2"},{"groupId":"FG008","numSubjects":"1"},{"groupId":"FG009","numSubjects":"2"},{"groupId":"FG010","numSubjects":"4"},{"groupId":"FG011","numSubjects":"12"},{"groupId":"FG012","numSubjects":"11"},{"groupId":"FG013","numSubjects":"25"},{"groupId":"FG014","numSubjects":"18"},{"groupId":"FG015","numSubjects":"0"},{"groupId":"FG016","numSubjects":"6"},{"groupId":"FG017","numSubjects":"5"},{"groupId":"FG018","numSubjects":"13"},{"groupId":"FG019","numSubjects":"13"},{"groupId":"FG020","numSubjects":"5"},{"groupId":"FG021","numSubjects":"3"},{"groupId":"FG022","numSubjects":"2"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"1"},{"groupId":"FG007","numSubjects":"3"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"2"},{"groupId":"FG011","numSubjects":"1"},{"groupId":"FG012","numSubjects":"0"},{"groupId":"FG013","numSubjects":"1"},{"groupId":"FG014","numSubjects":"4"},{"groupId":"FG015","numSubjects":"0"},{"groupId":"FG016","numSubjects":"2"},{"groupId":"FG017","numSubjects":"0"},{"groupId":"FG018","numSubjects":"1"},{"groupId":"FG019","numSubjects":"1"},{"groupId":"FG020","numSubjects":"0"},{"groupId":"FG021","numSubjects":"0"},{"groupId":"FG022","numSubjects":"1"}],"type":"other reason"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"},{"groupId":"FG010","numSubjects":"0"},{"groupId":"FG011","numSubjects":"1"},{"groupId":"FG012","numSubjects":"1"},{"groupId":"FG013","numSubjects":"0"},{"groupId":"FG014","numSubjects":"1"},{"groupId":"FG015","numSubjects":"0"},{"groupId":"FG016","numSubjects":"1"},{"groupId":"FG017","numSubjects":"0"},{"groupId":"FG018","numSubjects":"0"},{"groupId":"FG019","numSubjects":"0"},{"groupId":"FG020","numSubjects":"0"},{"groupId":"FG021","numSubjects":"0"},{"groupId":"FG022","numSubjects":"1"}],"type":"Lost to Follow-up"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"15"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"18"},{"groupId":"FG003","numSubjects":"50"},{"groupId":"FG004","numSubjects":"3"},{"groupId":"FG005","numSubjects":"49"},{"groupId":"FG006","numSubjects":"52"},{"groupId":"FG007","numSubjects":"16"},{"groupId":"FG008","numSubjects":"3"},{"groupId":"FG009","numSubjects":"18"},{"groupId":"FG010","numSubjects":"30"},{"groupId":"FG011","numSubjects":"81"},{"groupId":"FG012","numSubjects":"61"},{"groupId":"FG013","numSubjects":"145"},{"groupId":"FG014","numSubjects":"96"},{"groupId":"FG015","numSubjects":"3"},{"groupId":"FG016","numSubjects":"55"},{"groupId":"FG017","numSubjects":"58"},{"groupId":"FG018","numSubjects":"92"},{"groupId":"FG019","numSubjects":"104"},{"groupId":"FG020","numSubjects":"41"},{"groupId":"FG021","numSubjects":"43"},{"groupId":"FG022","numSubjects":"42"}],"comment":"started = number of Participants regardless of continuing treatment or not.","type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"12"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"15"},{"groupId":"FG003","numSubjects":"40"},{"groupId":"FG004","numSubjects":"3"},{"groupId":"FG005","numSubjects":"41"},{"groupId":"FG006","numSubjects":"40"},{"groupId":"FG007","numSubjects":"10"},{"groupId":"FG008","numSubjects":"2"},{"groupId":"FG009","numSubjects":"16"},{"groupId":"FG010","numSubjects":"19"},{"groupId":"FG011","numSubjects":"59"},{"groupId":"FG012","numSubjects":"47"},{"groupId":"FG013","numSubjects":"107"},{"groupId":"FG014","numSubjects":"66"},{"groupId":"FG015","numSubjects":"3"},{"groupId":"FG016","numSubjects":"41"},{"groupId":"FG017","numSubjects":"50"},{"groupId":"FG018","numSubjects":"76"},{"groupId":"FG019","numSubjects":"83"},{"groupId":"FG020","numSubjects":"32"},{"groupId":"FG021","numSubjects":"34"},{"groupId":"FG022","numSubjects":"36"}],"comment":"completed = continuing to be followed","type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"10"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"8"},{"groupId":"FG006","numSubjects":"12"},{"groupId":"FG007","numSubjects":"6"},{"groupId":"FG008","numSubjects":"1"},{"groupId":"FG009","numSubjects":"2"},{"groupId":"FG010","numSubjects":"11"},{"groupId":"FG011","numSubjects":"22"},{"groupId":"FG012","numSubjects":"14"},{"groupId":"FG013","numSubjects":"38"},{"groupId":"FG014","numSubjects":"30"},{"groupId":"FG015","numSubjects":"0"},{"groupId":"FG016","numSubjects":"14"},{"groupId":"FG017","numSubjects":"8"},{"groupId":"FG018","numSubjects":"16"},{"groupId":"FG019","numSubjects":"21"},{"groupId":"FG020","numSubjects":"9"},{"groupId":"FG021","numSubjects":"9"},{"groupId":"FG022","numSubjects":"6"}],"type":"NOT COMPLETED"}],"title":"Follow-up Period"}],"preAssignmentDetails":"1131 participants were treated in total for TNBC, GC, PC, SCLC, BC and OC."}